The EAP 2026 Annual Paediatric Forum & MasterCourse will take place from 30 April to 3 May 2026 in Tbilisi, bringing paediatricians together for an intensive, practice-oriented educational experience.
Designed as one of EAP’s flagship learning activities, the MasterCourse focuses on current clinical challenges, evolving standards of care, and real-world application, offering participants the opportunity to engage directly with European experts and peers in a highly interactive setting.
Unlike large-scale congresses, the EAP MasterCourse is built around in-depth teaching, discussion and exchange, making it particularly valuable for paediatricians seeking structured updates that can be translated into daily practice.
The programme brings together international faculty and participants to explore key topics in paediatric care, while the Annual Paediatric Forum provides a space for broader professional dialogue within the EAP community.
Participants are invited to submit abstracts for presentation at the EAP 2026 Annual Paediatric Forum & MasterCourse. Abstracts offer an opportunity to share clinical experience, research and innovative practice within a focused European paediatric forum.
Follow us on social media to stay up to date with the latest news, deadlines, and community highlights! Be part of the CEPAS journey from the very beginning!
To support broad international participation, simultaneous translation will be available in more than 60 languages, ensuring an inclusive learning environment for both local and international delegates.
Group registrations are also available, offering a cost-effective option for departments, hospitals and training programmes wishing to attend together and encourage shared learning.
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
